Approach to Treating Precocious Puberty

Initial Diagnostic Evaluation

The American Academy of Pediatrics recommends documenting the precise age when secondary sexual characteristics first appeared, as onset before age 8 in girls or age 9 in boys defines precocious puberty and warrants endocrine evaluation 2
The Endocrine Society suggests distinguishing true precocious puberty from isolated variants, as the first sign of HPG axis activation in girls is breast development (thelarche), not pubic hair, and isolated pubic or axillary hair represents adrenarche, not true precocious puberty 1
Assessing the rate of pubertal progression, including breast development (Tanner staging), pubic hair, growth velocity, and timing of menarche, is crucial to determine the urgency of intervention 1, 2

Measuring baseline gonadotropins (FSH, LH) and estradiol is essential to determine if central (gonadotropin-dependent) or peripheral (gonadotropin-independent) precocious puberty is present 1

Obtaining a bone age X-ray is necessary to assess skeletal maturation and predict the impact on final height 1
Brain MRI is mandatory for girls under 6 years, as they have the highest risk (>90%) of CNS abnormalities causing CPP 1

The American College of Obstetricians and Gynecologists recommends treating girls with progressive CPP diagnosed before age 8 years to preserve final adult height and prevent psychosocial complications 1
Treatment is particularly beneficial for girls diagnosed before age 6, who have the highest risk of CNS abnormalities and greatest height compromise 1

Reviewing history of chemotherapy with alkylating agents or radiotherapy is crucial, as these patients require specific surveillance protocols 2
Patients with premature ovarian insufficiency from cancer treatment require different management, including hormone replacement therapy for pubertal induction, not GnRH suppression 3, 4
Evaluating for behavioral problems, mood symptoms, and psychosocial adjustment is essential, as early puberty is associated with increased risk of behavioral problems, obesity, metabolic disorders, and psychological distress 1, 2